Patient receiving a comprehensive information about the study, and not opposed to participate
\+ one criterion among :
patient hospitalized fo a COVID-19
Patient with known APS
Patients hospitalized for an acute venous thromboembolism event aPL positivity or COVID-19
healthy volunteers
You may not be if
For all participants : pregnancy, age below 18 years-old, absence of written informed consent , autoimmune or inflammatory disease except antiphospholipid syndrome
For patients with COVID-19: previous aPL positivity (before COVID-19 infection)
For patients with APS: previous symptomatic COVID-19 infection
For patients control with acute venous thromboembolism event: previous symptomatic COVID-19 infection, infection or inflammatory disease in flare at the time of thromboembolism event, known aPL positivity
For Healthy volunteers: history of thrombosis (venous, arterial or small vessels), previous symptomatic COVID-19 infection, infection or inflammatory disease in flare at the time of inclusion, known aPL positivity
Clareo Health | Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)
